EX-99.1 2 ex991.htm EXHIBIT 99.1 ex991.htm
Exhibit 99.1
 
eMagin Posts Record Revenue and Operating Income for Second Quarter of 2008
 
Grows Q2 Revenue 33% and Positive Operating Income
 
BELLEVUE, Wash.--(BUSINESS WIRE)-- eMagin Corporation (OTCBB:EMAN), the leader in OLED microdisplays, issued financial results for its second quarter ending June 30, 2008.
 
Financial Summary
 
 
·  
Revenue for the three and six months ending June 30, 2008, of approximately $5.6 million and $8.3 million, represent increases of 33% and 6% from $4.2 million and $7.8 million for the same periods in 2007.
 
·  
Gross margins in 2008 grew to 47% of revenue or $2.6 million for the quarter and 36% or $3 million for the six-month period as compared to 30% of revenue or $1.3 million for the quarter and 23% or $1.8 million for the six-month period in 2007. These results were due to higher volume and better yield.
 
·  
Operating expenses declined 4% and 13% from $2.3 million and $4.8 million for the three and six month periods ending June 30, 2008, as compared to $2.4 million and $5.5 million in 2007.
 
·  
Operating income for the three months ending June 30, 2008 totaled $0.3 million compared to an operating loss of $1.1 million in 2007. For the six-month period, losses were $1.8 million in 2008, down 51% or $1.9 million from $3.7 million in 2007.
 
"I am pleased to announce that the Company has achieved positive operating income the second quarter of 2008, and we initiated a path forward that we believe will result in increased profitability with a lower cost structure and improved yields,“ said Andrew G. Sculley, chief executive officer and president, eMagin Corporation.
 
Selected Business Highlights
 
·  
At the Society for Information Display Conference, eMagin demonstrated its enhanced SVGA+ microdisplay, which the Company believes to be the most power efficient OLED solution for near-eye applications. Better power efficiency results in lighter and/or longer lasting mobile display products.
 
·  
eMagin is now shipping first samples of its new higher resolution microdisplay. Besides great contrast and a SXGA or 1280x1024 format at 0.77-inch diagonal, this display has outstanding power efficiency. The company’s measurements show that it is at least 4 times more power efficient than competitive products.
 
Full results will be available in the company's 10Q report for the quarter ending June 30, 2008, to be filed with the SEC.
 
About eMagin Corporation
 
A leader in OLED microdisplay technology, eMagin produces and sells high-resolution OLED microdisplays that can be used with magnifying optics to deliver virtual images comparable to large-screen computer and television displays in portable, low-power, lightweight personal displays. eMagin microdisplays provide near-eye imagery in a variety of products from military, industrial, medical and consumer OEMs. The company's own Z800 3DVisor provides 3D stereovision and headtracking for PC gaming, training and simulation, immersion therapy, and other applications. eMagin's microdisplay manufacturing and R&D operations are co-located with IBM on its campus in East Fishkill, New York. System design facilities and sales and marketing are located in Bellevue, Washington. More information about eMagin and its products is available at www.emagin.com.
 
Forward Looking Statements
 
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including those regarding eMagin Corporation's expectations, intentions, strategies and beliefs pertaining to future events or future financial performance. Actual events or results may differ materially from those in the forward-looking statements as a result of various important factors, including those described in the Company's most recent filings with the SEC. Although we believe that the expectations reflected in the forward-looking statements are reasonable, such statements should not be regarded as a representation by the Company, or any other person, that such forward-looking statements will be achieved. The business and operations of the Company are subject to substantial risks which increase the uncertainty inherent in forward-looking statements. We undertake no duty to update any of the forward-looking statements, whether as a result of new information, future events or otherwise. In light of the foregoing, readers are cautioned not to place undue reliance on such forward-looking statements.
 
Note: eMagin is a trademark of eMagin Corporation.
 
Contacts
eMagin Corporation
Investors:
Paul Campbell, 425-749-3600
pcampbell@emagin.com
 
or
 
Business Development:
Susan Jones, 425-749-3614
sjones@emagin.com
 
1

 
 
eMAGIN CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except share data)
             
   
June 30, 2008
(unaudited)
   
December 31, 2007
 
             
ASSETS
           
             
Current assets:
           
Cash and cash equivalents
  $ 1,038     $ 713  
Investments – held to maturity
    94       94  
Accounts receivable, net
    3,601       2,383  
Inventory
    1,726       1,815  
Prepaid expenses and other current assets
    750       850  
Total current assets
    7,209       5,855  
Equipment, furniture and leasehold improvements, net
    401       292  
Intangible assets, net
    49       51  
Other assets
    232       232  
Deferred financing costs, net
    135       218  
Total assets
  $ 8,026     $ 6,648  
                 
LIABILITIES AND CAPITAL DEFICIT
               
                 
Current liabilities:
               
Accounts payable
  $ 1,135     $ 620  
Accrued compensation
    962       891  
Other accrued expenses
    704       729  
Advance payments
    13       35  
Deferred revenue
    80       179  
Current portion of  debt
    8,148       7,089  
Other current liabilities
    596       1,020  
Total current liabilities
    11,638       10,563  
                 
Long-term debt
    41       60  
    Total liabilities
    11,679       10,623  
                 
Commitments and contingencies
               
                 
Capital deficit:
               
Preferred stock, $.001 par value: authorized 10,000,000 shares; no shares issued and outstanding
           
       Series A Senior Secured Convertible Preferred stock, stated value $1,000 per share, $.001 par value:  3,198 shares designated and none issued
           
Common stock, $.001 par value: authorized 200,000,000 shares, issued and outstanding, 14,389,439 shares as of June 30, 2008 and 12,620,900 shares as of December 31, 2007
    14       12  
Additional paid-in capital
    198,442       195,326  
Accumulated deficit
    (202,109 )     (199,313 )
Total capital deficit
    ( 3,653 )     ( 3,975 )
Total liabilities and capital deficit
  $ 8,026     $ 6,648  
                 
 
 
2

 
 
 
eMAGIN CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except share and per share data)
(unaudited)

   
Three Months Ended
June 30,
   
Six Months Ended
June 30,
 
   
2008
   
2007
   
2008
   
2007
 
Revenue:
                       
                         
Product revenue
  $ 4,496     $ 4,144     $ 6,958     $ 7,667  
Contract revenue
    1,123       88       1,326       174  
                                 
Total revenue, net
    5,619       4,232       8,284       7,841  
                                 
Cost of goods sold
    2,996       2,946       5,309       6,061  
                                 
Gross profit
    2,623       1,286       2,975       1,780  
                                 
Operating expenses:
                               
                                 
Research and development
    634       887       1,308       1,740  
Selling, general and administrative
    1,697       1,543       3,504       3,764  
Total operating expenses
    2,331       2,430       4,812       5,504  
                                 
Income (loss) from operations
    292       (1,144 )     (1,837 )     (3,724 )
                                 
Other income (expense):
                               
                                 
  Interest expense
    (537 )     (1,333 )     (1,168 )     (2,174 )
  Gain on warrant derivative liability
          182             643  
  Other income, net
    123       567       209       590  
    Total other expense
    (414 )     (584 )     (959 )     (941 )
                                 
Net loss
  $ (122 )   $ (1,728 )   $ (2,796 )   $ (4,665 )
                                 
                                 
Loss per share, basic and diluted
  $ (0.01 )   $ (0.15 )   $ (0.21 )   $ (0.42 )
                                 
Weighted average number of shares outstanding:
                               
                                 
Basic and diluted
    14,320,570       11,175,888       13,470,735       10,983,981  
                                 


3